Premium
Implementation of defined criteria for clinical pharmacists in a pediatric cardiac transplant ambulatory clinic
Author(s) -
Kiskaddon Amy L.,
Brown Brian K.,
Carapellucci Jennifer,
Wisotzkey Bethany L.,
AsanteKorang Alfred
Publication year - 2021
Publication title -
journal of the american college of clinical pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2574-9870
DOI - 10.1002/jac5.1410
Subject(s) - medicine , psychological intervention , ambulatory , clinical pharmacy , discontinuation , medicaid , accreditation , pharmacist , pharmacy , family medicine , emergency medicine , pediatrics , nursing , health care , economics , medical education , economic growth
Abstract Introduction The United Network of Organ Sharing (UNOS) bylaws and Centers for Medicare and Medicaid Services (CMS) accreditation standards require that transplant centers have a pharmacist. However, there are no established guidelines and there is a paucity of literature describing pharmacists in the pediatric ambulatory setting. Objective This project aims to describe the activities of pediatric clinical pharmacists in an ambulatory pediatric cardiac transplant clinic. Methods This is a single‐center pilot project describing pediatric clinical pharmacist interventions before (phase I) and after (phase II) implementation of comprehensive and standardized clinical activities. The list of defined key clinical activities was developed using UNOS and CMS accreditation standards, an evaluation of the literature, and cardiac transplant team feedback. Results Prior to a defined list of clinical activities, pediatric clinical pharmacists saw 74 unique patients during 174 patient encounters and recorded 240 interventions (phase I). Following implementation of standard activities, pediatric clinical pharmacists saw 81 unique patients during 225 patient encounters and recorded 510 interventions (phase II). The development of defined key activities led to a 129.4% increase in documented interventions per patient encounter. Interventions with the greatest increase included: medication schedule (phase I, 13.2%; phase II, 37.3%; P < .001), medication dose adjustment (phase I, 5.7%; phase II, 22.2%; P < .001), outpatient pharmacy coordination (phase I, 1.1%; phase II, 15.6%; P < .001), medication discontinuation (phase I, 0.6%; phase II, 9.3%; P < .001), and medication adherence education (phase I, 0%; phase II, 6.2%; P < .001). Conclusion There was a significant increase in the number and variety of medication‐related interventions after the development and implementation of defined key clinical activities for pediatric clinical pharmacists in a pediatric cardiac transplant ambulatory care clinic.